BCL2 and melanoma: In addition, lncRNA-XIST promotes the proliferation and migration of melanoma cells by decreasing the expression of PI3KRI and AKT and increasing the expression of Bcl-2 and Bax, which are considered key regulators of oxaliplatin resistance in melanoma progression (5).